TL;DR
This study reveals that the transcription factor RBP-J is a critical regulator of Ly6C<sup>lo</sup> monocyte populations in the blood and lungs. By controlling CCR2 expression, RBP-J influences monocyte circulation and their subsequent differentiation into lung-resident macrophages, highlighting a key mechanism in myeloid homeostasis.
What Problem Does This Paper Address?
Monocytes are crucial immune cells that differentiate into various tissue-resident macrophages and dendritic cells, playing vital roles in both health and disease. These cells exist in distinct subsets, with Ly6C<sup>hi</sup> and Ly6C<sup>lo</sup> monocytes being the primary types in mice. While Ly6C<sup>hi</sup> monocytes are known for their inflammatory roles, the precise functions and regulation of Ly6C<sup>lo</sup> monocytes, particularly their role in maintaining tissue homeostasis and their contribution to resident macrophage populations, are less understood. Specifically, the molecular mechanisms governing the balance and function of these monocyte subsets, and how they contribute to tissue-resident immune cell populations, remain an open question. This paper investigates the role of Notch signaling, mediated by the transcription factor RBP-J, in regulating the homeostasis and function of Ly6C<sup>lo</sup> monocytes.
Methods
The researchers employed a multi-pronged approach to investigate RBP-J's role in monocyte biology:
- Genetic Manipulation: They used conditional knockout mice with RBP-J specifically deleted in myeloid cells (Rbpj<sup>fl/fl</sup>Lyz2<sup>cre/cre</sup> mice) to study the consequences of RBP-J loss.
- Flow Cytometry: This was a central technique for identifying and quantifying different monocyte subsets (Ly6C<sup>hi</sup>, Ly6C<sup>lo</sup>) and other immune cells based on surface marker expression (e.g., CD11b, Ly6G, CD115, CD117, CD135, CX3CR1, CCR2, CD11c, CD16.2, CD64, CD206).
- Bone Marrow Transplantation: This technique allowed them to assess the cell-intrinsic role of RBP-J by generating chimeric mice where RBP-J deficient or sufficient bone marrow cells were engrafted.
- Parabiosis: This surgical procedure, where two mice are joined to share circulation, helped determine if RBP-J deficiency in monocytes affected their ability to circulate and compete in the bloodstream in a cell-intrinsic manner.
- RNA-sequencing (RNA-seq): Used to perform gene expression profiling of Ly6C<sup>lo</sup> monocytes to identify differentially expressed genes in RBP-J deficient versus control mice.
- Quantitative RT-PCR (qPCR): Used to validate gene expression changes observed in RNA-seq, particularly for genes like Rbpj, Nr4a1, and Ccr2.
- Cell Proliferation Assays: EdU incorporation and Ki-67 staining were used to assess the proliferation rates of monocyte subsets.
- Cell Death Assays: Annexin V and 7-AAD staining were used to identify apoptotic cells.
- In Vivo Labeling: Latex beads were injected to track monocyte turnover and survival.
- Immunofluorescence Histology: Used to visualize cell populations in lung tissue.
- Intranasal LPS Challenge: This model was used to induce inflammation in the lungs and assess the recruitment and differentiation of monocytes.
Datasets
Not discussed in the paper.
Key Insights and Ideas
- RBP-J is a Gatekeeper for Ly6C<sup>lo</sup> Monocytes: The most striking finding is that RBP-J deficiency leads to a significant over-accumulation of Ly6C<sup>lo</sup> monocytes in the blood. This suggests RBP-J normally acts to keep these cells in check.
- CCR2 is the Key Mediator: The study strongly implicates CCR2 as the primary target through which RBP-J controls Ly6C<sup>lo</sup> monocyte numbers. RBP-J deficiency increases CCR2 expression, which in turn drives the accumulation of these monocytes.
- Cell-Intrinsic Control: Bone marrow transplantation and parabiosis experiments clearly demonstrate that RBP-J's role in regulating Ly6C<sup>lo</sup> monocyte populations is intrinsic to the monocytes themselves, not dependent on other cell types.
- Lung Homeostasis is Affected: The increased circulating Ly6C<sup>lo</sup> monocytes in RBP-J deficient mice don't just stay in the blood; they migrate to the lungs, leading to an expansion of Ly6C<sup>lo</sup> monocytes and CD16.2<sup>+</sup> interstitial macrophages in this tissue. This highlights a direct link between blood monocyte populations and tissue-resident immune cells.
- CCR2 Deletion Rescues Phenotype: Genetically deleting CCR2 in RBP-J deficient mice normalized the increased Ly6C<sup>lo</sup> monocyte numbers, providing strong evidence for CCR2's central role in this pathway.
Key Results
- Increased Ly6C<sup>lo</sup> Monocytes: RBP-J deficient mice showed a significant increase in blood Ly6C<sup>lo</sup> monocytes, but not Ly6C<sup>hi</sup> monocytes.
- Lung Accumulation: RBP-J deficiency led to a marked increase in Ly6C<sup>lo</sup> monocytes and CD16.2<sup>+</sup> interstitial macrophages in the lungs.
- Cell-Intrinsic Effect: Bone marrow transplantation experiments showed that RBP-J deficient donor cells contributed disproportionately to blood Ly6C<sup>lo</sup> monocytes in recipient mice. Parabiosis experiments confirmed that RBP-J deficient monocytes had an enhanced ability to circulate.
- CCR2 Upregulation: RNA-seq and qPCR revealed that RBP-J deficient Ly6C<sup>lo</sup> monocytes had significantly higher expression of Ccr2 and lower expression of Itgax (a marker for Ly6C<sup>lo</sup> monocytes) compared to controls.
- CCR2 Deletion Corrects Phenotype: In RBP-J/CCR2 double knockout mice, the increased Ly6C<sup>lo</sup> monocyte numbers were normalized to control levels.
- No Impact on Survival/Proliferation: RBP-J deficiency did not affect the survival, proliferation, or conversion of Ly6C<sup>hi</sup> to Ly6C<sup>lo</sup> monocytes.
Limitations and Future Work
- Steady-State Focus: The study primarily focuses on steady-state conditions. Future work could explore RBP-J's role in monocyte regulation during inflammatory or infectious challenges.
- Mechanisms of CCR2 Regulation: While RBP-J's role in regulating CCR2 is shown, the precise transcriptional mechanisms by which RBP-J controls Ccr2 expression remain to be fully elucidated.
- Other Notch Receptors: The study focuses on RBP-J, the downstream effector of Notch signaling. Investigating the specific Notch receptors (e.g., Notch1, Notch2) involved in this pathway could provide further insights.
- Broader Monocyte Functions: While the study highlights CCR2 and CD11c expression, further investigation into other functional aspects of RBP-J deficient Ly6C<sup>lo</sup> monocytes (e.g., phagocytosis, cytokine production) would be valuable.
Summary updated